- Home
- GDTC vs DARE Comparison
GDTC vs DARE Comparison
Compare GDTC & DARE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GDTC
- DARE
- Stock Information
- Founded
- GDTC 2018
- DARE 2015
- Country
- GDTC Singapore
- DARE United States
- Employees
- GDTC N/A
- DARE N/A
- Industry
- GDTC Biotechnology: Pharmaceutical Preparations
- DARE Biotechnology: Pharmaceutical Preparations
- Sector
- GDTC Health Care
- DARE Health Care
- Exchange
- GDTC Nasdaq
- DARE Nasdaq
- Market Cap
- GDTC 28.0M
- DARE 26.3M
- IPO Year
- GDTC 2023
- DARE N/A
- Fundamental
- Price
- GDTC $2.21
- DARE $2.52
- Analyst Decision
- GDTC Buy
- DARE Strong Buy
- Analyst Count
- GDTC 1
- DARE 3
- Target Price
- GDTC $5.00
- DARE $12.50
- AVG Volume (30 Days)
- GDTC 6.5K
- DARE 443.5K
- Earning Date
- GDTC 01-01-0001
- DARE 08-11-2025
- Dividend Yield
- GDTC N/A
- DARE N/A
- EPS Growth
- GDTC N/A
- DARE N/A
- EPS
- GDTC N/A
- DARE N/A
- Revenue
- GDTC $368,838.00
- DARE $25,909.00
- Revenue This Year
- GDTC $5.37
- DARE $99,756.91
- Revenue Next Year
- GDTC N/A
- DARE $119.77
- P/E Ratio
- GDTC N/A
- DARE N/A
- Revenue Growth
- GDTC N/A
- DARE N/A
- 52 Week Low
- GDTC $1.20
- DARE $2.11
- 52 Week High
- GDTC $4.05
- DARE $4.60
- Technical
- Relative Strength Index (RSI)
- GDTC 49.36
- DARE 41.75
- Support Level
- GDTC $2.09
- DARE $2.37
- Resistance Level
- GDTC $2.35
- DARE $2.54
- Average True Range (ATR)
- GDTC 0.10
- DARE 0.14
- MACD
- GDTC 0.00
- DARE -0.00
- Stochastic Oscillator
- GDTC 50.00
- DARE 59.56
About GDTC CytoMed Therapeutics Limited
CytoMed Therapeutics Ltd is a pre-clinical biopharmaceutical company focused on harnessing its proprietary technologies to create novel cell-based immunotherapies for the treatment of human cancers. The development of its novel technologies has been inspired by the clinical success of existing CAR-T cells in treating hematological malignancies as well as the current clinical limitations and commercial challenges in extrapolating the CAR-T principle into the treatment of solid tumors. Geographically, the company operates in Singapore and Malaysia which is the majority revenue generator.
About DARE Dare Bioscience Inc.
Dare Bioscience Inc is a biopharmaceutical company committed to advancing products for women's health. The company identifies, develops, and brings to market a diverse portfolio of differentiated therapies that prioritize women's health and well-being, expand treatment options, and improve outcomes, in the areas of contraception, fertility, and vaginal and sexual health. The company's first product, XACIATO is a single-dose vaginal gel prescription product for the treatment of bacterial vaginosis in females 12 years of age and older. The company's portfolio includes two product candidates in clinical development namely, Ovaprene and Sildenafil Cream. It has one operating segment, women's health.